The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes

Primary Care Diabetes

Volumn 6, Issue 1, 2012, Pages 53-59

  Lind, Marcus ^a,b   Fahlén, Martin ^c   Eliasson, Björn ^a   Odén, Anders ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UDDEVALLA HOSPITAL   (Sweden)

^c Kungalv Hospital   (Sweden)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Cancer; Diabetes; Glargine; Insulin; Time

Indexed keywords

INSULIN GLARGINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RESEARCH; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; SWEDEN;

ADULT; AGED; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 84858070444     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2011.10.004     Document Type: Article

References (19)

1. L.G. Hemkens, U. Grouven, and R. Bender Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 September 2009 1732 1744
2. J.M. Jonasson, R. Ljung, M. Talbäck, B. Haglund, S. Gudbjörnsdttir, and G. Steineck Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden Diabetologia 52 September (9) 2009 1745 1754
3. H.M. Colhoun Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 September (9) 2009 1755 1765
4. C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 September (9) 2009 1766 1777
5. S.C. Larsson, N. Orsini, and A. Wolk Diabetes mellitus and risk of colorectal cancer: a meta-analysis J. Natl. Cancer Inst. 97 November (22) 2005 1679 1687 (Pubitemid 41672234)
6. R. Huxley, A. Ansary-Moghaddam, A. Berrington de Gonzalez, F. Barzi, and M. Woodward Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies Br. J. Cancer 92 2005 2076 2083 (Pubitemid 40897433)
7. S.C. Larsson, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of breast cancer: a meta-analysis Int. J. Cancer 121 2007 856 862 (Pubitemid 47106217)
8. E. Giovannucci, D.M. Harlan, and M.C. Archer Diabetes and cancer: a consensus report Diabetes Care 33 July (7) 2010 1674 1685
9. D.W. Gaylor The use of Harbers Law in standard setting and risk assessment Toxicology 149 August (1) 2000 17 19 (Pubitemid 30645783)
10. R.E. Shore, V. Iver, B. Altshuler, and B.S. Pasternack Use of human data in quantitative risk assessment of carcinogens: impact on epidemiologic practice and the regulatory process Regul. Toxicol. Pharmacol. 15 Apr (2 Pt 1) 1992 180 221
11. A. Monro How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? Adverse Drug React. Toxicol. Rev. 12 Spring (1) 1993 5 34 (Pubitemid 23165885)
12. M. Lind, M. Fahlén, M. Happich, A. Odén, and B. Eliasson The effect of insulin lispro on glycemic control in a large patient cohort Diabetes Technol. Ther. 11 2009 51 56
13. M. Lind, A. Odén, M. Fahlén, and B. Eliasson The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables PLoS ONE 4 2009 e4412
14. Diab-Base. Available from http://www.journalia.se (accessed 10.04.10).
15. M. Lind, A. Odén, M. Fahlén, and B. Eliasson The shape of the metabolic memory of HbA1c: re-analyzing the DCCT with respect to time-dependent effects Diabetologia 53 June (6) 2010 1093 1098
16. T. Simonsson, K. Sjölund, P. Bümming, H. Ahlman, B. Nilsson, and A. Odén Reducing uncertainty in health-care resource allocation Br. J. Cancer 96 June (12) 2007 1834 1838 (Pubitemid 46912015)
17. Data from the Cancer Register in Sweden. Available from http://www.cancerregistret.se (accessed 10.04.10).
18. R. Ljung, N. Talbäck, and B. Haglund Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation Acta Oncol. 50 June (5) 2011 685 693
19. E. Mannucci, M. Monami, D. Balzi, B. Cresci, L. Pala, C. Melani, C. Lamanna, I. Bracali, M. Bigiarini, A. Barchielli, N. Marchionni, and C.M. Rotella Doses of insulin and its analogues and cancer occurrence in insulin treated type 2 diabetic patients Diabetes Care 33 September (9) 2010 1997 2003